A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 May 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

04 Oct 2017 Status changed from active, no longer recruiting to completed.
05 Apr 2017 Results of development and validation of population PK model of MEDI0680 (n=56) and sequential PK-PD analysis (n=35), presented at the 108th Annual Meeting of the American Association for Cancer Research
20 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Aug 2017.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com